Xian Zhou

发表

Semiparametric random censorship models for survival data with long-term survivors

Yan Feng, Xiaobing Zhao, Xian Zhou, 2018, Commun. Stat. Simul. Comput..

RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer.

Xian Zhou, Edith A Perez, E. Perez, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.